Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Sunday, September 27

3:30 PM - 3:40 PM ET

103 - Predicting Survival from Appearance: A Multimodal Deep Learning Model Integrating Facial Photographs and MRI
Speaker: Chen, Zihang, MD - University of Texas Southwestern Medical Center at Dallas, Dallas, TX
3:30 PM - 3:40 PM ET

108 - Three-Year Outcomes of a Prospective Randomized Trial of Moderately-Hypofractionated and Standard-Fractionated Proton Therapy in Prostate Cancer Embedded within COMPPARE Trial
Speaker: Mendenhall, Nancy, MD, FASTRO - University of Florida Proton Therapy Institute, Jacksonville, FL
3:30 PM - 3:40 PM ET

113 - MR-ADAPTOR: Randomized Phase II Trial of Weekly MRI-Guided Volumetric Adaptation and Elective Neck Deintensification for Low-Risk HPV-Associated OPSCC
Speaker: Floyd, Warren, MD, PhD, BS - MD Anderson Cancer Center, Houston, TX
3:30 PM - 3:40 PM ET

118 - Beyond Malignancy: Addressing the Educational Gap in Radiation Therapy for Non-Malignant Diseases: An ARRO-jDEGRO Initiative
Speaker: Kutuk, Tugce, MD - Miami Cancer Institute, Miami, FL
3:30 PM - 3:40 PM ET

124 - Biology-Guided Radiotherapy In Pan-HPV Head and Neck Cancer Using Genomic-Adjusted Radiation Dose
Speaker: Bergman, Drew, MD - Memorial Sloan Kettering Cancer Center, New York, NY
3:35 PM - 3:55 PM ET

Question and Answers
Speaker: Liu, Kevin, MD, DPhil - Brigham and Womens Hospital, Boston, MA
3:35 PM - 3:55 PM ET

Questions & Answers
Speaker: Corbin, Kimberly, MD - Mayo Clinic, Rochester, MN
3:40 PM - 3:50 PM ET

104 - Multimodal Artificial Intelligence Model for Predicting Treatment Efficacy and Optimizing Upfront Cranial Radiotherapy Selection in Third-Generation EGFR-TKI-Treated NSCLC with Brain Metastases
Speaker: Pang, Yechun - Fudan University Shanghai Cancer Center, Shanghai, DC
3:40 PM - 3:50 PM ET

109 - <em>I</em>ntermittent Androgen Deprivation Therapy with or without <em>St</em>ereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive <em>O</em>ligometastatic <em>P</em>rostate Cancer: A Randomized Study (i-STOP)
Speaker: Glicksman, Rachel, MD - University of Toronto, Toronto, ON
3:40 PM - 3:50 PM ET

114 - Oncologic Outcomes of a Multicenter Prospective Study Evaluating ctHPVDNA-Adapted Adjuvant Radiotherapy in Patients with HPV-Associated Oropharyngeal Cancer
Speaker: Bates, James, MD - Emory University, Atlanta, GA
3:40 PM - 3:50 PM ET

119 - Assessing Burnout and Retention Risk Among Radiation Therapists During Departmental Expansion
Speaker: Webking, Samantha, MD - Moffitt Cancer Center, Tampa, FL
3:40 PM - 3:50 PM ET

125 - Phase I Trial with Expansion Cohort of DNA-PK Inhibitor Peposertib and Intensity Modulated Radiation Treatment (IMRT) in Cisplatin-Ineligible Patients with Stage 3-4 Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Speaker: Samuels, Michael, MD - University of Miami Miller School of Medicine, Miami, FL